Home Newsfeeds Needham Maintains Buy on CryoPort, Raises Price Target to $42

Needham Maintains Buy on CryoPort, Raises Price Target to $42

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $41 to $42.

byBenzinga Newsdesk

July 12, 2022

1 minute read

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $41 to $42.

As Stock Is Down 34% This Year, 3 NXP Semiconductors Analysts Weigh In On Results, Guidance

By Priya Nigam

November 1, 11:14 AM

NXP Semiconductors NV (NASDAQ: NXPI) Monday announced mixed third-quarter earnings and downbeat guidance. Raymond James On NXP Semiconductors

NXPI

Catalyst Biosciences Q2 EPS $1.64 Up From $(0.64) YoY

By Benzinga Newsdesk

August 15, 4:47 PM

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly earnings of $1.64 per share. This is a 356.25 percent increase over losses of $(0.64) per share from the same period last year.

CBIO

Analyst Ratings

HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here’s What You Need To Know

By Benzinga Insights

December 29, 1:01 PM

HC Wainwright & Co. has decided to maintain its Buy rating of TG Therapeutics (NASDAQ:TGTX) and raise its…

TGTX

Web Presence Sector Players GoDaddy, Wix, And Squarespace Get Bullish Rating From This Analyst – Here’s Why

By Anusuya Lahiri

October 24, 2:46 PM

Seaport analyst Aaron Kessler initiated coverage of ten companies within the Internet Sector.

GDDY

Needham Maintains Buy on CryoPort, Raises Price Target to $42

Related Posts

As Stock Is Down 34% This Year, 3 NXP Semiconductors Analysts Weigh In On Results, Guidance

Catalyst Biosciences Q2 EPS $1.64 Up From $(0.64) YoY

HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here’s What You Need To Know

Web Presence Sector Players GoDaddy, Wix, And Squarespace Get Bullish Rating From This Analyst – Here’s Why